Published in Animals (Basel) on September 08, 2011
Novel amidines and analogues as promising agents against intracellular parasites: a systematic review. Parasitology (2013) 1.07
Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice. Int J Parasitol Drugs Drug Resist (2012) 0.87
In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites. Antimicrob Agents Chemother (2013) 0.80
Differential Effects on Survival, Humoral Immune Responses and Brain Lesions in Inbred BALB/C, CBA/CA, and C57BL/6 Mice Experimentally Infected with Neospora caninum Tachyzoites. ISRN Parasitol (2013) 0.77
Cloning, Nucleotide Sequencing and Bioinformatics Study of NcSRS2 Gene, an Immunogen from Iranian Isolate of Neospora caninum. Iran J Parasitol (2013) 0.77
Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model. Pathogens (2013) 0.77
The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates. Int J Parasitol (2017) 0.76
Host species heterogeneity in the epidemiology of Nesopora caninum. PLoS One (2017) 0.75
Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science (2002) 4.26
Intracellular parasite invasion strategies. Science (2004) 3.36
Newly recognized fatal protozoan disease of dogs. J Am Vet Med Assoc (1988) 2.89
Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev (2007) 2.51
Pulling together: an integrated model of Toxoplasma cell invasion. Curr Opin Microbiol (2006) 2.37
Review of Neospora caninum and neosporosis in animals. Korean J Parasitol (2003) 2.14
Neosporosis in animals--the last five years. Vet Parasitol (2011) 1.80
Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology (2006) 1.67
Unusual kinetic and structural properties control rapid assembly and turnover of actin in the parasite Toxoplasma gondii. Mol Biol Cell (2005) 1.50
Invasion and intracellular survival by protozoan parasites. Immunol Rev (2011) 1.43
Aldolase is essential for energy production and bridging adhesin-actin cytoskeletal interactions during parasite invasion of host cells. Cell Host Microbe (2009) 1.39
Neospora caninum: role for immune cytokines in host immunity. Exp Parasitol (1997) 1.29
Chasing the golden egg: vaccination against poultry coccidiosis. Parasite Immunol (2010) 1.19
Pathogenesis of bovine neosporosis. J Comp Pathol (2006) 1.19
The comparative pathogenesis of neosporosis. Trends Parasitol (2002) 1.17
Effect of congenitally acquired Neospora caninum infection on risk of abortion and subsequent abortions in dairy cattle. Am J Vet Res (1997) 1.14
Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine (2001) 1.12
Molecular and immunodiagnostic investigations on bovine neosporosis in Switzerland. Int J Parasitol (1998) 1.09
A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria. Vaccine (2008) 1.08
Toxoplasmosis: the first commercial vaccine. Parasitol Today (1993) 1.06
Neospora caninum--how close are we to development of an efficacious vaccine that prevents abortion in cattle? Int J Parasitol (2009) 1.03
Neospora caninum-infected cattle develop parasite-specific CD4+ cytotoxic T lymphocytes. Infect Immun (2003) 1.03
Endogenous and exogenous transplacental transmission of Neospora caninum - how the route of transmission impacts on epidemiology and control of disease. Parasitology (2009) 1.03
Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology (2003) 1.00
Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J Parasitol (2005) 0.98
The host-parasite relationship in pregnant cattle infected with Neospora caninum. Parasitology (2007) 0.97
Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Infect Immun (2006) 0.97
Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol (2003) 0.97
Supranational comparison of Neospora caninum seroprevalences in cattle in Germany, The Netherlands, Spain and Sweden. Vet Parasitol (2006) 0.97
Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Infect Immun (2006) 0.97
Neospora caninum infection in birds: experimental infections in chicken and embryonated eggs. Parasitology (2007) 0.96
Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Vet Parasitol (2004) 0.96
Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Int J Parasitol (2008) 0.96
Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int J Parasitol (2009) 0.96
Isolation and characterization of a bovine isolate of Neospora caninum with low virulence. Vet Parasitol (2008) 0.96
Isolation and genetic characterization of Neospora caninum from asymptomatic calves in Spain. Parasitology (2008) 0.95
Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination. Int J Parasitol (2005) 0.94
Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite. PLoS Pathog (2011) 0.94
Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora caninum infection. Parasite Immunol (1999) 0.94
Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol Res (2007) 0.94
Experimental infection with a low virulence isolate of Neospora caninum at 70 days gestation in cattle did not result in foetopathy. Vet Res (2009) 0.93
Field application of a subunit vaccine against an enteric protozoan disease. PLoS One (2008) 0.93
If control of Neospora caninum infection is technically feasible does it make economic sense? Vet Parasitol (2006) 0.92
Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninum. Int J Parasitol (2011) 0.92
Comparative host-parasite relationships in ovine toxoplasmosis and bovine neosporosis and strategies for vaccination. Vaccine (2007) 0.91
Studies on serological cross-reaction of Neospora caninum with Toxoplasma gondii and Hammondia heydorni. J Vet Med Sci (2002) 0.91
Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J Parasitol (1999) 0.91
Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice. Exp Parasitol (2010) 0.89
Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. J Parasitol (2003) 0.88
Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens. Int J Parasitol (2007) 0.88
Pathogenic characterization in mice of Neospora caninum isolates obtained from asymptomatic calves. Parasitology (2010) 0.87
Influence of Neospora caninum intra-specific variability in the outcome of infection in a pregnant BALB/c mouse model. Vet Res (2010) 0.87
Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Int J Parasitol (2005) 0.87
Evidence for host cells as the major contributor of lipids in the intravacuolar network of Toxoplasma-infected cells. Eukaryot Cell (2011) 0.87
Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum. Vaccine (2011) 0.86
Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum. Parasitology (2007) 0.86
Histopathological and clinical investigations in Neospora caninum experimentally infected broiler chicken embryonated eggs. Vet Parasitol (2009) 0.86
Inclusion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves protection against congenital neosporosis. Infect Immun (2004) 0.86
CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice. Vaccine (2009) 0.86
Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Prev Vet Med (2006) 0.86
Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice. Clin Vaccine Immunol (2009) 0.84
Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens. Int J Parasitol (2007) 0.84
Vaccination of chickens with a chimeric DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2 induces protective immunity against coccidiosis. Vet Parasitol (2008) 0.84
Neospora caninum protein disulfide isomerase is involved in tachyzoite-host cell interaction. Int J Parasitol (2005) 0.84
Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet Parasitol (2005) 0.84
Immunisation of mice against neosporosis. Int J Parasitol (2002) 0.83
Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Prev Vet Med (2006) 0.83
Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites. Parasite Immunol (2011) 0.83
Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production. Infect Immun (2005) 0.83
Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine (2008) 0.82
Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Vaccine (2007) 0.82
Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant. Vaccine (2010) 0.82
Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine (2006) 0.82
Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum. J Parasitol (2007) 0.82
Experimental infection of sheep with Neospora caninum oocysts. J Parasitol (2002) 0.82
A previous infection with Toxoplasma gondii does not protect against a challenge with Neospora caninum in pregnant sheep. Parasite Immunol (2001) 0.82
Antigen-specific CD8+ T cells protect against lethal toxoplasmosis in mice infected with Neospora caninum. Infect Immun (1998) 0.82
Re-evaluating the economics of neosporosis control. Vet Parasitol (2008) 0.82
Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice. Vaccine (2009) 0.81
Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum. J Eukaryot Microbiol (2006) 0.81
Molecular characterization of Neospora caninum MAG1, a dense granule protein secreted into the parasitophorous vacuole, and associated with the cyst wall and the cyst matrix. Parasitology (2010) 0.81
Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria. Malar J (2010) 0.80
Immunity to experimental neosporosis in pregnant sheep. Parasite Immunol (2001) 0.80
Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection. Korean J Parasitol (2005) 0.80
Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum. Vet Parasitol (2011) 0.80
Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice. Vet Parasitol (2010) 0.79
Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis. Exp Parasitol (2007) 0.79
A longitudinal study of Neospora caninum infection on a dairy farm in New Zealand. Prev Vet Med (2002) 0.78
Immune response to Neospora caninum native antigens formulated with immune stimulating complexes in calves. Vet Parasitol (2010) 0.78
Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine (2007) 0.78
Neospora caninum emerges from the shadow of Toxoplasma gondii. Trends Parasitol (2006) 0.78
Pigeons (Columba livia) are a suitable experimental model for Neospora caninum infection in birds. Vet Parasitol (2008) 0.78
Genetic manipulation of Neospora caninum to express the bradyzoite-specific protein NcSAG4 in tachyzoites. Parasitology (2011) 0.77
Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain. Infect Immun (2009) 0.77
Neospora caninum infections in Australia and New Zealand. Aust Vet J (2000) 0.77
Evaluation of vaccination with Neospora caninum protein for prevention of fetal loss associated with experimentally induced neosporosis in sheep. Am J Vet Res (2004) 0.77
Neospora caninum and bone marrow-derived dendritic cells: parasite survival, proliferation, and induction of cytokine expression. Parasite Immunol (2009) 0.77
Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses. Parasitol Res (2011) 0.77